Exosome-based Analysis of 442 Small Noncoding Rnas in Urine to Evaluate Risk of Prostate Cancer
Exosome-based analysis of 442 small noncoding rnas in urine to evaluate risk of prostate cancer. Clinical pricing breakdown and utilization metrics across 1 practicing doctors nationwide.
Understanding This Medical Fee
Gross Charge vs Negotiated Payment: The median physician charge for this service is $1200.00. However, insured patients almost never pay this full amount directly. Insurers negotiate rates down toward the $744.80 baseline.
Self-Pay & Uninsured Guidance: If you are paying without insurance or out-of-network, request a prompt-pay cash discount. Most medical practices are willing to settle self-pay bills near the customary baseline rate rather than the full gross charge.
- "Does Dr. [Name] participate in my specific insurance plan network?"
- "What is the total self-pay or cash rate for code 0343U if paid upfront?"
- "Are there separate facility, anesthesia, or pathology fees associated with this procedure?"
Top Doctors Performing Exosome-based Analysis of 442 Small Noncoding Rnas in Urine to Evaluate Risk of Prostate Cancer
High-volume practitioners verified for this specific clinical procedure
Frequently Searched Medical Procedures
Compare pricing across other high-volume clinical benchmarks